Publications
GWAS and meta-analyses identifies 49 genetic variants underlying critical COVID-19.
Pairo-Castineira E, Rawlik K, Bretherick AD, ..., Millar JE, ..., Baillie JK.
Nature (2023)
DOI: 10.1038/s41586-023-06034-3Extracorporeal carbon dioxide removal in acute hypoxaemic respiratory failure: a systematic review, Bayesian meta-analysis, and trial sequential analysis.
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the ISARIC WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study.
Reyes LF, Murthy S, Garcia-Gallo E, ..., Millar JE, ..., Olliaro PL.
Eur. Respir. J. Open Res. (2022)
DOI: 10.1183/23120541.00552-2021Validation of mRNA markers expressed in human ARDS subgroups in an ovine model of ARDS phenotypes.
Whole genome sequencing reveals host factors underlying critical COVID-19.
Kousathanas A, Pairo-Castineira E, Rawlik K, ..., Millar JE, ..., Baillie JK.
Nature (2022)
DOI: 10.1038/s41586-022-04576-6Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study.
SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures.
Winslow RL, Zhou J, Windle EF, ..., Millar JE, ...Green CA.
Thorax (2022)
DOI: 10.1136/thoraxjnl-2021-218035Apples and oranges: international comparisons of COVID-19 observational studies in ICUs.
Millar JE, Busse R, Fraser JF, et. al.
Lancet Respir. Med. (2021)
DOI: 10.1016/S2213-2600(20)30368-4Current understanding of leukocyte phenotypic and functional modulation during extracorporeal membrane oxygenation: a narrative review.
Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute hypoxemic respiratory failure: the REST randomized trial.
McNamee JJ, Gillies MA, Barrett NA, ..., Millar JE, ..., McAuley DF.
JAMA (2021)
DOI: 10.1001/jama.2021.13374